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Cyclic AMP-regulated exocytosis 
of E. coli from infected bladder 
epithelial cells
Th e superfi cial bladder epithelium is a powerful barrier to 
urine and also serves as a regulator of bladder volume, which 
is achieved by apical exocytosis of specialized fusiform vesicles 
during distension of the bladder.
Th e urinary tract is one of the major mucosal sites for 
microbial colonization. Th e pathogen most eff ective at 
overcoming the mucosal barriers is uropathogenic E. coli, the 
causative agent of 90% of urinary tract infections. Th e success 
of E. coli as a uropathogen is linked to the expression of type 1 
fi mbriae, fi lamentous appendages that enable uropathogenic 
E. coli both to bind and to invade the superfi cial bladder 
epithelial cells lining the bladder lumen. Bacterial invasion 
follows the binding of type 1 fi mbriae to uroplakin 1a, a 
major component of the large scallop-shaped plaques found 
on the apical surface of superfi cial bladder epithelial cells. 
Th ese plaques arise from the fusion to the apical membrane 
of a dynamic pool of discoid vesicles, called fusiform vesicles. 
Exocytosis of fusiform vesicles helps regulate bladder surface 
area during the accumulation of urine. Urine accumulation 
triggers the initiation in bladder epithelial cells of fusiform 
vesicle exocytosis, by a cyclic adenosine monophosphate 
(cAMP)-dependent mechanism. Traffi  cking of the fusiform 
vesicles to the plasma membrane is regulated in part by 
intracellular cAMP and calcium levels as well as the small 
guanosine triphosphate (GTP)ase Rab27b. To elucidate the 
mechanism underlying uropathogenic E. coli invasion, Bishop 
et al. focused on the interactions between these bacteria and 
the superfi cial epithelium in a mouse model. Th ey found 
that type 1 fi mbriated uropathogenic E. coli circumvented 
the bladder barrier by harboring in Rab27b/CD63-positive 
and cAMP-regulatable fusiform vesicles within bladder 
epithelial cells (see Figure). Incorporation of the bacteria into 
the bladder epithelial cell fusiform compartments enabled 
bacteria to escape elimination during voiding and to re-emerge 
in the urine as the bladder distended. Notably, the authors 
also found that treatment of uropathogenic E. coli-infected 
mice with a drug that increases intracellular cAMP induced 
exocytosis of fusiform vesicles and reduced the number 
of intracellular E. coli. Th e use of traditional antibiotics in 
the treatment of urinary tract infections is plagued by their 
inadequate penetration of bladder epithelial cells, which 
allows intracellular bacteria to persist. Th us, the discovery that 
cAMP regulates the intracellular niche of uropathogenic E. coli 
reveals a new and potentially eff ective strategy for combating 
urinary tract infection. Eliminating the small but important 
intracellular pool of bacteria may have large clinical benefi ts. 
(Nat Med 2007; 13: 625–630)
Juan Oliver
Aldosterone impairs vascular 
reactivity by decreasing glucose-6-
phosphate dehydrogenase activity
Hyperaldosteronism is associated with impaired vascular 
reactivity in individuals with aldosterone-producing adrenal 
adenomas, hypertension, or congestive heart failure. Th ese 
conditions are improved markedly aft er surgical resection of the 
adenoma or treatment with spironolactone. Th e mechanisms 
by which aldosterone adversely infl uences vascular reactivity 
remain unclear; however, it has been suggested that aldosterone 
may increase vascular reactive oxygen species (ROS) and 
decrease endothelium-derived nitric oxide (NO•).
Glucose-6-phosphate dehydrogenase (G6PD), the fi rst 
and rate-limiting enzyme in the pentose phosphate pathway, 
is the principal intracellular source of the reduced form of 
nicotinamide adenine dinucleotide phosphate (NADPH). 
NADPH serves as a reducing equivalent to limit ROS and 
maintain levels of reduced glutathione (GSH). Th us, G6PD 
is a critical determinant of the intracellular redox state and 
provides a redox environment that favors NO•. When G6PD 
activity is defi cient, endothelial cells challenged with oxidants 
demonstrate increased ROS and decreased GSH stores, 
whereas cells that overexpress G6PD remain resistant to redox 
imbalance. G6PD-derived NADPH also serves as a cofactor 
for the endothelial isoform of nitric oxide synthase (eNOS). 
Th e importance of G6PD for eNOS activity is revealed when 
NADPH stores are depleted: eNOS uncouples and generates 
superoxide in preference to NO•. In contrast, overexpression of 
G6PD increases eNOS activity and augments NO• formation.
E. coli entry into Rab27b+ vesicles within bladder epithelial cells.
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Studies have shown that specifi c glucocorticoid, 
mineralocorticoid, and sex steroid compounds can inhibit 
G6PD activity, but the eff ect of aldosterone on G6PD activity 
has not been tested. However, dehydroepiandrosterone, which 
is structurally similar to aldosterone, was found to be a potent 
inhibitor of G6PD, and aldosterone has been shown to decrease 
G6PD activity in rat myocardial homogenates. Th us, Leopold 
et al. examined whether aldosterone induces a G6PD-defi cient 
state and thus promotes vascular dysfunction.
Th ey found that aldosterone decreased endothelial G6PD 
expression and activity in vitro, resulting in increased oxidant 
stress and decreased NO• levels — similar to what is observed 
in G6PD-defi cient endothelial cells (see Figure). Aldosterone 
decreased G6PD expression by increasing expression of 
the cAMP-response element modulator (CREM) to inhibit 
cAMP-response element binding protein (CREB)-mediated 
G6pd transcription. In vivo, infusion of aldosterone increased 
blood pressure, decreased vascular G6PD expression, and 
impaired vascular reactivity (see Figure). Th ese eff ects were 
abrogated by spironolactone or vascular gene transfer of 
G6pd. Th ese fi ndings demonstrate that aldosterone induces 
a G6PD-defi cient phenotype to impair endothelial function; 
aldosterone antagonism or gene transfer of G6pd improves 
vascular reactivity by restoring G6PD activity. (Nat Med 2007; 
13: 189–197)
Juan Oliver
PAX2 activation during urinary 
tract obstruction
Acute obstruction of the urinary tract initiates a complex 
series of events in the kidney, which lead to programmed cell 
death in tubular cells and rapid loss of renal parenchyma. In 
rodents, tubular apoptosis is dramatically increased within 
approximately 5 days aft er unilateral ureteral obstruction.
During fetal life, cells of the collecting duct lineage are 
relatively protected from programmed cell death, in great part 
because of the “paired-box” transcription factor PAX2. Mice 
bearing heterozygous mutations of the PAX2 genes exhibit 
a marked increase in ureteric bud cell apoptosis during fetal 
life. As a consequence, ureteric bud branching is suboptimal, 
and these mice are born with a reduced nephron number. In 
addition, apoptosis is increased when endogenous PAX2 levels 
in cultured collecting duct cells are reduced by transfection 
with antisense Pax2 cDNA.
Recent work has shown that acute tubular necrosis induces 
PAX2 expression during the process of regeneration. Cohen et 
al. hypothesized that Pax2 could be involved in the evolution 
of obstructive renal disease. Wild-type and heterozygous 
Pax2 mutant (Pax21Neu) mice underwent unilateral ureteric 
ligation or sham operation and had their kidneys examined 
aft er 5, 10, and 15 days. PAX2 protein fell to low levels in the 
fi rst weeks of life. In addition, it was sharply reactivated by 
day 10 in collecting duct cells of wild-type, but not Pax21Neu 
mutant, mice with unilateral ureteric ligation (see Figure). 
Wild-type mice had marked terminal deoxynucleotidyl 
transferase-mediated dUTP nick end labeling (TUNEL) signal 
in tubular cells and reduced kidney weight aft er 10–15 days. 
However, mutant mice had exaggerated increases in markers 
of apoptosis and exaggerated renal parenchymal loss in the 
obstructed kidney. Th ese observations indicate that PAX2 
is rapidly reactivated in unilateral ureteric ligation, and 
that mice with genetically limited PAX2 expression have 
heightened susceptibility to cell death and renal damage. 
Th us, PAX2 appears to have a renoprotective role during 
urinary obstruction. (Am J Physiol Renal Physiol 2007; 292: 
F1267–F1273)
Juan Oliver
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 Unilateral left ureteral obstruction.
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After 14 days of aldosterone infusion, aortae were harvested and G6PD 
expression was examined by immunohistochemistry.
Le
op
ol
d 
et
 a
l./
N
at
 M
ed
